Early-stage Mesothelioma
2 clinical trials · Condition
◉ Watch Early-stage Mesothelioma
| Record | Firm | Date |
|---|---|---|
| Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma (NCT06654050) | National Cancer Institute (NCI) | 2026-03-16 |
| Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma (NCT05960773) | National Cancer Institute (NCI) | 2024-01-31 |
Track Early-stage Mesothelioma automatically
Every clearance here is in the API, with alerts when new ones post.